Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07645495
Frequency Rhythmic Electrical Modulated Stimulation Therapy in Chronic Ulcers.Beni-Suef UniversityNot Yet RecruitingNot Applicable
NCT07645495Not Yet Recruiting
Not Applicable
Frequency Rhythmic Electrical Modulated Stimulation Therapy in Chronic Ulcers.Beni-Suef University
NCT07645690
The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell CarcinomaChinese PLA General HospitalRecruitingEarly Phase 1
NCT07645690Recruiting
Early Phase 1
The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Meta...Chinese PLA General Hospi...
NCT07645339
Efficacy and Safety of a Topical Botanical Extract Formulation for Skin Barrier RepairL'OrealActive Not RecruitingNot Applicable
NCT07645339Active Not Recruiting
Not Applicable
Efficacy and Safety of a Topical Botanical Extract Formulation for Skin Barrier...L'Oreal
NCT07644091
Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer PatientsMethodist Health SystemRecruiting
NCT07644091Recruiting
—
Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer Pa...Methodist Health System
NCT07646093
Weight-Adjusted Diclofenac Potassium Medicated Lollipop for Post-Adenotonsillectomy Pain in ChildrenHospital Universitario de CaracasCompletedNot Applicable
NCT07646093Completed
Not Applicable
Weight-Adjusted Diclofenac Potassium Medicated Lollipop for Post-Adenotonsillect...Hospital Universitario de...
NCT07644052
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use DisorderPleoPharma, Inc.RecruitingPhase 3
NCT07644052Recruiting
Phase 3
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cann...PleoPharma, Inc.
NCT07644299
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Concept StudyCiusss de L'Est de l'Île de MontréalNot Yet RecruitingNot Applicable
NCT07644299Not Yet Recruiting
Not Applicable
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Co...Ciusss de L'Est de l'Île...
NCT07646509
An Ecological Momentary Intervention for the Reduction of Impairment in Somatic Symptom DisorderUniversity of ViennaRecruitingNot Applicable
NCT07646509Recruiting
Not Applicable
An Ecological Momentary Intervention for the Reduction of Impairment in Somatic...University of Vienna
NCT07645937
Effects of Low-Load Blood Flow Restriction Exercise on Rectus Femoris Muscle Morphology in Individuals With Relapsing-Remitting Multiple SclerosisDicle UniversityNot Yet RecruitingNot Applicable
NCT07645937Not Yet Recruiting
Not Applicable
Effects of Low-Load Blood Flow Restriction Exercise on Rectus Femoris Muscle Mor...Dicle University
NCT07643805
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCLThe First Affiliated Hospital with Nanjing Medical UniversityNot Yet RecruitingPhase 1
NCT07643805Not Yet Recruiting
Phase 1
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Pat...The First Affiliated Hosp...
NCT07645833
Eptinezumab for Chronic Headache in Idiopathic Intracranial HypertensionH. Lundbeck A/SNot Yet RecruitingPhase 3
NCT07645833Not Yet Recruiting
Phase 3
Eptinezumab for Chronic Headache in Idiopathic Intracranial HypertensionH. Lundbeck A/S
NCT07645560
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic StrokeBeijing Tiantan HospitalNot Yet RecruitingPhase 2
NCT07645560Not Yet Recruiting
Phase 2
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After...Beijing Tiantan Hospital
NCT07644169
A Clinical Trial to Assess the Pharmacokinetic Profile of Propylene Glycol (PG) in Healthy Adults Following PG ExposureAmerican Beverage AssociationNot Yet RecruitingNot Applicable
NCT07644169Not Yet Recruiting
Not Applicable
A Clinical Trial to Assess the Pharmacokinetic Profile of Propylene Glycol (PG)...American Beverage Associa...
NCT07643831
Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2- Early or Locally Advanced/Metastatic Breast CancerGenentech, Inc.Unknown
NCT07643831Unknown
—
Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2-...Genentech, Inc.
NCT07645235
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating WomenBiomedical Advanced Research and Development AuthorityNot Yet RecruitingPhase 1
NCT07645235Not Yet Recruiting
Phase 1
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Wom...Biomedical Advanced Resea...
NCT07645170
Strain Counter-Strain vs Maitland Mobilization for Sacroiliac Joint PainUniversity of FaisalabadActive Not RecruitingNot Applicable
NCT07645170Active Not Recruiting
Not Applicable
Strain Counter-Strain vs Maitland Mobilization for Sacroiliac Joint PainUniversity of Faisalabad
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07646028
R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS)Rise Therapeutics LLCNot Yet RecruitingPhase 1
NCT07646028Not Yet Recruiting
Phase 1
R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS)Rise Therapeutics LLC
NCT07646314
Comparative Effects of Post-Isometric Relaxation and Reciprocal Inhibition Techniques inPiriformis SyndromeRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07646314Not Yet Recruiting
Not Applicable
Comparative Effects of Post-Isometric Relaxation and Reciprocal Inhibition Techn...Riphah International Univ...
NCT07644403
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.Suzhou Immunofoco Biotechnology Co., LtdEnrolling By InvitationPhase 1
NCT07644403Enrolling By Invitation
Phase 1
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid...Suzhou Immunofoco Biotech...
Result Breakdown
Not yet recruiting10 (50%)
Recruiting5 (25%)
Active, not recruiting2 (10%)
Completed1 (5%)
Unknown1 (5%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Phase 14 (20%)
Not Specified2 (10%)
Phase 32 (10%)
Phase 22 (10%)
Early Phase 11 (5%)